0002088485-25-000001.txt : 20250926 0002088485-25-000001.hdr.sgml : 20250926 20250926162526 ACCESSION NUMBER: 0002088485-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250926 DATE AS OF CHANGE: 20250926 EFFECTIVENESS DATE: 20250926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tinos Therapeutics, Inc. CENTRAL INDEX KEY: 0002088485 ORGANIZATION NAME: EIN: 923339664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-558952 FILM NUMBER: 251350889 BUSINESS ADDRESS: STREET 1: 34 BOYCE AVENUE CITY: BARRINGTON STATE: RI ZIP: 02806 BUSINESS PHONE: 570-939-7415 MAIL ADDRESS: STREET 1: 34 BOYCE AVENUE CITY: BARRINGTON STATE: RI ZIP: 02806 D 1 primary_doc.xml X0708 D LIVE 0002088485 Tinos Therapeutics, Inc. 34 BOYCE AVENUE BARRINGTON RI RHODE ISLAND 02806 570-939-7415 DELAWARE None None Corporation true 2023 Nikolaos Tapinos 34 Boyce Avenue Barrington RI RHODE ISLAND 02806 Executive Officer Director David Karambizi 34 Boyce Avenue Barrington RI RHODE ISLAND 02806 Executive Officer Director Anastasios Polimenakos 34 Boyce Avenue Barrington RI RHODE ISLAND 02806 Director Biotechnology Decline to Disclose 06b false 2025-09-04 false true false 0 1500000 1000000 500000 false 1 0 0 0 false Tinos Therapeutics, Inc. /s/ Nikolaos Tapinos Nikolaos Tapinos President 2025-09-26